No Data
No Data
Freedom Capital Markets Initiates LifeMD(LFMD.US) With Buy Rating, Announces Target Price $13
Insider Sale: Chief Marketing Officer of $LFMD Sells 30,000 Shares
LifeMD (NASDAQ:LFMD) Delivers Shareholders Massive 37% CAGR Over 5 Years, Surging 27% in the Last Week Alone
Mizuho Securities Reaffirms Their Hold Rating on LifeMD (LFMD)
H.C. Wainwright Maintains LifeMD(LFMD.US) With Buy Rating, Raises Target Price to $14
LifeMD Is Maintained at Buy by HC Wainwright & Co.
loading...
NAN_BULL : May I ask at what age you semi-retired?
JST_ : awesome! thanks for sharing![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
JoeskiTheRookie : good luck to you.
韩寒就是好的北京市开 :
like your post real life .. I'm also in the same shoe 
72655275 : Wishing you good luck.
View more comments...